TITLE

Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer

AUTHOR(S)
Bosco, Jaclyn L. F.; Halpenny, Barbara; Berry, Donna L.
PUB. DATE
January 2012
SOURCE
Health & Quality of Life Outcomes;2012, Vol. 10 Issue 1, p123
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Men diagnosed with localized prostate cancer (LPC) can choose from multiple treatment regimens and are faced with a decision in which medical factors and personal preferences are important. The Personal Patient Profile-Prostate (P3P) is a computerized decision aid for men with LPC that focuses on personal preferences. We determined whether the P3P intervention improved the concordance of treatment choice with self-reported influential side-effects compared with a control group. Methods: English/Spanish-speaking men diagnosed with LPC (2007-2009) from four US cities were enrolled into a randomized trial and followed through 6-months via mailed or online questionnaire. Men were randomized to receive the P3P intervention or standard education plus links to reputable websites. We classified choice as concordant if men were concerned with (a) sexual function and chose external beam radiotherapy or brachytherapy, (b) bowel function and chose prostatectomy, (c) sex, bowel, and/or bladder function and chose active surveillance, or (d) not concerned with any side effect and chose any treatment. Using logistic regression, we calculated odds ratios (OR) and 95% confidence intervals (CI) for the association between the P3P intervention and concordance. Results: Of 448 men, most were <65 years, non-Hispanic white, had multiple physician consultations prior to enrollment, and chose a treatment discordant with concerns about potential side effects. There was no significant difference in concordance between the intervention (45%) and control (50%) group (OR = 0.82; 95%CI = 0.56, 1.2). Conclusions: The P3P intervention did not improve concordance between potential side effects and treatment choice. Information and/or physician consultation immediately after diagnosis was likely to influence decisions despite concerns about side effects. The intervention may be more effective before the first treatment options consultation.
ACCESSION #
84413225

 

Related Articles

  • Focal therapy in prostate cancer: the current situation. Jácome-Pita, F. X.; Sánchez-Salas, R.; Barret, E.; Amaruch, N.; Gonzalez-Enguita, C.; Cathelineau, X. // Ecancermedicalscience;2014, Vol. 8 Issue 413-446, p1 

    Prostate cancer is one of the most significant pathologies in the field of urology. The adoption of screening strategies and improvements in biopsies have resulted in an increase in early-stage tumour detection. Radical global therapies provide very good oncological results in localised prostate...

  • Quality of life after prostate cancer treatments in patients comparable at baseline. van Tol-Geerdink, J J; Leer, J W H; van Oort, I M; van Lin, E J N T; Weijerman, P C; Vergunst, H; Witjes, J A; Stalmeier, P F M // British Journal of Cancer;5/14/2013, Vol. 108 Issue 9, p1784 

    Background:Previous studies on the effects of different prostate cancer treatments on quality of life, were confounded because patients were not comparable. This study examined treatment effects in more comparable groups.Methods:From 2008-2011, 240 patients with localised prostate cancer were...

  • Extended Salvage Pelvic Lymph Node Dissection in Patients with Recurrent Prostate Cancer. Osmonov, Daniar K.; Aksenov, Alexey V.; Boller, Annkathrin; Kalz, Almut; Heimann, Diana; Janssen, Isa; Jünemann, Klaus-Peter // Advances in Urology;2014, p1 

    Background. Treatment of patients with a biochemical recurrence (BCR) of prostate cancer (PCa) is generally difficult and without valid treatment options. Since 2004 we have been developing therapeutic possibilities for these patients. Methods. We retrospectively analyzed a cohort of 41 patients...

  • Management of Urinary Incontinence after Prostate Cancer Treatment and Urethroplasty. McCammon, Kurt A. // AUANews;Apr2015, Vol. 20 Issue 4, p8 

    The article discusses the onset of urethral stricture or bladder neck contracture complications in prostate cancer patients treated with combined brachytherapy and external beam radiation therapy. It is noted that preoperative planning is necessary given the resulting urinary incontinence rates...

  • Corrigendum.  // Urologia Internationalis;Apr2014, Vol. 92 Issue 3, p372 

    No abstract available

  • New Weapons Against Prostate Cancer. Saltus, Richard // Popular Science;Aug2000, Vol. 257 Issue 2, p58 

    Provides information on several treatments for prostate cancer. Radical prostatectomy; External-beam therapy; Brachytherapy; X-ray treatment. INSETS: Catching Cancer Early;Hope from Herbs.

  • Use of brachytherapy for localized prostate cancer has declined. Todak, Alexandra // Hem/Onc Today;6/10/2014, Vol. 15 Issue 11, p7 

    The article reports on the downturn in the use of brachytherapy as treatment for men with lower-risk prostate cancer based on information from National Cancer Data Base institutions and mentions topics including rise in utilization of radical prostatectomy and active surveillance.

  • The Role of Radical Prostatectomy in the Treatment of Patients with High-Risk Prostate Cancer. Kuzgunbay, Barış; Yaycıoğlu, Özgür // Journal of Urological Surgery;Sep2015, Vol. 2 Issue 3, p120 

    High-risk prostate cancer (PCa), which is defined as PSA >20 ng/mL or Gleason Score (GS) >7 or ≥cT3a, accounts for up to 40% of newly diagnosed cases and carries a significant risk of progression and death. However, the best management approach for patients with high-risk PCa is still...

  • The best method for dose escalation: Prostate brachytherapy. Morton, Gerard // Canadian Urological Association Journal;Jun2012, Vol. 6 Issue 3, p196 

    The author discusses the role of radiation therapy dose in the treatment of prostate cancer. He informs that external beam radiotherapy dose increases the biochemical control rate to about 10 percent in five years and also mentions that brachytherapy is a safe method of dose escalation. He...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics